s.perrin

TL2 Moderator · Córdoba

Contributes reviews on supplier material. Based in Córdoba.

Joined 12 November 2024 · last posted 3d

87 posts, newest first. Showing up to 150.

What steady state means for the decision to escalate Replied, post #35 · Practice › Dosing & titration · 25 Jul 2026 · 0 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
CJC-1295 with and without DAC: what the modification does Replied, post #116 · Compounds › Secretagogues & GH axis · 19 Jul 2026 · 1 like Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large randomised controlled trials are rare. Most evidence is…
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #75 · Practice › Dosing & titration · 18 Jul 2026 · 0 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
[2026 update] Documenting an adverse event properly Replied, post #13 · Safety › Adverse events · 18 Jul 2026 · 23 likes Medullary thyroid carcinoma is the reason these compounds are contraindicated in people with personal or family history of MTC or multiple endocrine neoplasia type 2.…
I joined for one answer and stayed for a year — what changed my mind Replied, post #84 · Start Here › Welcome · 15 Jul 2026 · 11 likes The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not comprehensive but it is well indexed for the questions that come up most.
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #69 · Outcomes › Progress reports · 3 Jul 2026 · 6 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Journal club: STEP 8 and the fairness of the comparator dose — a second dataset Replied, post #17 · Evidence › Journal club · 26 Jun 2026 · 8 likes On post #13 — agreed on the reasoning, with one qualification. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose…
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #60 · Evidence › Journal club · 26 Jun 2026 · 29 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #17 · Analytics › Home & field testing · 21 Jun 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #78 · Safety › Contraindications · 18 Jun 2026 · 22 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
Submitting a sample: the process end to end Replied, post #21 · Sourcing › Independent verification · 16 Jun 2026 · 17 likes post #20 answers the question as asked. The question underneath it is different. Repeat testing: if you want to verify the same lot a second time, testing with a…
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #7 · Analytics › Home & field testing · 16 Jun 2026 · 2 likes Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at extremes and the correlation depends on the exact conditions…
Second pass at: Programming during a large energy deficit Replied, post #29 · Nutrition & Training › Resistance training · 15 Jun 2026 · 13 likes Picking up post #26: that is the part I would want checked first. Frequency: three sessions per week of full-body training is easier to maintain than higher frequencies…
A community side-effect dataset, with its response rate and biases Replied, post #2 · Data & Tools › Datasets · 12 Jun 2026 · 18 likes Using data in discussions: datasets are useful as reference points when someone claims something unusual. "I have not seen that reported in the data" is different from…
Racemisation and why it is invisible to a mass measurement Replied, post #68 · Analytics › Impurities & related substances · 12 Jun 2026 · 9 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Why the timeline is on the right and not the left — what changed since Replied, post #53 · Meta › Site feedback · 12 Jun 2026 · 19 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Blinding yourself: practical methods and their limits Replied, post #25 · Research Methods › N-of-1 designs · 13 May 2026 · 8 likes Generalisability: a robust n-of-1 result applies to you. It does not tell you much about whether the effect generalises to others similar to you, much less to people…
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #124 · Analytics › Mass spectrometry · 29 Apr 2026 · 9 likes Picking up post #121: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
What a certificate commits its issuer to — one year on Replied, post #53 · Analytics › COA interpretation · 20 Apr 2026 · 0 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #109 · Analytics › Mass spectrometry · 15 Apr 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Residual solvents and scavengers: what is looked for — what changed since Replied, post #27 · Analytics › Impurities & related substances · 13 Apr 2026 · 0 likes On post #23 — agreed on the reasoning, with one qualification. Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue.…
List price versus negotiated price versus what you pay Replied, post #15 · Access › Pricing · 9 Apr 2026 · 9 likes Worth separating two things that post #11 runs together. Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen…
Revisiting: Absolute versus relative contraindications Replied, post #61 · Safety › Contraindications · 7 Apr 2026 · 20 likes Coming back to post #59, because the follow-up matters more than the original answer. Severe hepatic impairment: less is known than for kidney disease. Extreme caution…
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #10 · Practice › Interactions · 14 Mar 2026 · 21 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
About the Preprints category Replied, post #5 · Evidence › Preprints · 13 Mar 2026 · 0 likes Preprints for speed: some important preliminary findings are posted as preprints to disseminate quickly. That speed is useful but comes at the cost of not yet having…
Follow-up: Search filters: what is missing Replied, post #48 · Meta › Site feedback · 7 Mar 2026 · 4 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Reference intervals: how they are constructed and why one in twenty flags Replied, post #59 · Clinical › Bloodwork · 4 Mar 2026 · 18 likes Picking up post #56: that is the part I would want checked first. Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #56 · Pharmacology › Pharmacokinetics · 28 Feb 2026 · 3 likes This follows post #53 rather than contradicting it. Individual variation: people vary in how quickly they absorb, distribute, metabolise, and excrete these compounds.…
Measurement error in a self-reported exposure Replied, post #105 · Evidence › Study critique · 27 Feb 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Mass error in ppm: the arithmetic and the caveat Replied, post #74 · Analytics › Mass spectrometry · 14 Feb 2026 · 0 likes Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report whether desalting was used, because it can affect the…
Trifluoroacetate content and its consequences Replied, post #63 · Analytics › Impurities & related substances · 1 Feb 2026 · 4 likes Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue. Chromatographically they usually elute earlier or later depending on the…
A partial dose because the pen emptied mid-injection Replied, post #58 · Practice › Administration · 9 Jan 2026 · 20 likes Coming back to post #56, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
Publication bias detection and its low power — does this still hold? Replied, post #5 · Evidence › Meta-analyses · 3 Jan 2026 · 2 likes I read post #3 twice before replying, because I had assumed the opposite. Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator,…
Lipase elevation without symptoms: the interpretation problem Replied, post #18 · Clinical › Bloodwork · 28 Dec 2025 · 3 likes Coming back to post #16, because the follow-up matters more than the original answer. Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel.…
Aggregates and why a purity assay may miss them entirely Replied, post #32 · Analytics › Impurities & related substances · 27 Dec 2025 · 28 likes Truncation products: fragments from incomplete synthesis or from degradation. They elute quite differently from the intact peptide because they are much smaller and…
Promotion criteria, and the one that stops most nominations — the long version Replied, post #120 · Documentation › Doc review · 27 Dec 2025 · 6 likes Revision disputes: if you disagree with an edit a maintainer made to a page, discuss it here. The goal is accuracy and clarity, not authorship.
Revisiting: Absolute versus relative contraindications Replied, post #8 · Safety › Contraindications · 14 Dec 2025 · 7 likes This follows post #5 rather than contradicting it. Gastroparesis or severe delayed gastric emptying: these compounds slow gastric emptying. Pre-existing severe…
Comparing two chromatograms from different laboratories, properly Replied, post #36 · Analytics › HPLC & UHPLC · 30 Nov 2025 · 0 likes post #35 is right about the mechanism and I think understates the practical bit. System suitability testing: injections run before and during the sample run to…
MHRA statements, read directly Replied, post #23 · Regional › UK & Ireland · 29 Oct 2025 · 2 likes Ireland: the Health Products Regulatory Authority implements EU framework. Prescription-only. Reimbursement for weight management has been more restrictive than for…
Gauge and length selection for subcutaneous injection Replied, post #43 · Devices › Syringes & needles · 25 Oct 2025 · 27 likes Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12 mm (longer). Longer needles are needed for deeper tissue or if…
New subcategory: rationale and scope Replied, post #45 · Meta › Announcements · 17 Oct 2025 · 22 likes Picking up post #42: that is the part I would want checked first. Notifications: watching this subcategory means you receive notifications when announcements are…
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #37 · Start Here › Welcome · 15 Oct 2025 · 20 likes Your introduction is well framed. You have given enough context that people can actually answer. That is rarer than it sounds and it matters more than it sounds.
Sleep tracking data and its considerable limitations Replied, post #9 · Wellbeing › Sleep · 15 Oct 2025 · 24 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #37 · Wellbeing › Mental health · 13 Oct 2025 · 13 likes Social and relationship impacts: weight change affects how others perceive and interact with a person. Those impacts are real and can be psychologically significant.
Coming back to: What happens when a maintainer goes quiet Replied, post #11 · Documentation › Doc review · 3 Oct 2025 · 0 likes New maintainer recruitment: if a page's maintainer is inactive and updates are needed, suggesting a new maintainer here can help transition responsibility.
[2026 update] Scheduled maintenance and what will be unavailable Replied, post #14 · Meta › Announcements · 2 Oct 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #118 · Compounds › Retatrutide · 27 Sep 2025 · 20 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
Compounds this community declines to help with, and why Replied, post #10 · Compounds › Other compounds · 24 Sep 2025 · 31 likes How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another. The honest position is that you are reasoning from…
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #20 · Lounge › Off topic · 4 Sep 2025 · 3 likes Lower-stakes conversation that does not belong in the technical categories. Still civil, still sourced when a claim is made, but the bar for relevance is lower.
[2026 update] Long-time reader, first-time poster Replied, post #7 · Lounge › Introductions · 27 Aug 2025 · 0 likes On post #3 — agreed on the reasoning, with one qualification. Say hello. No question required. Introduce yourself if you want to give context for why you are here, or…
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #93 · Compounds › Secretagogues & GH axis · 24 Aug 2025 · 4 likes post #92 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #58 · Evidence › Journal club · 18 Aug 2025 · 5 likes post #57 is right about the mechanism and I think understates the practical bit. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the…
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #76 · Access › Insurance & coverage · 11 Aug 2025 · 4 likes Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and…
Are there stupid questions here? A staff answer, at length Replied, post #61 · Start Here › Welcome · 11 Aug 2025 · 21 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
[2026 update] Splitting an overlong document into two Replied, post #23 · Documentation › Wiki requests · 10 Aug 2025 · 1 like Flag a page that has drifted: if you notice a maintained page has information that is outdated (dates that have passed, regulatory changes, new evidence) post a flag so…
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #93 · Compounds › Repair & healing peptides · 6 Aug 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
A ten-fold dose error caught before injection — one year on Replied, post #55 · Devices › Syringes & needles · 2 Aug 2025 · 0 likes Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to the hub). Luer-lock syringes use detachable needles (more dead…
Pages past their review date, listed Replied, post #10 · Meta › Wiki maintenance · 26 Jul 2025 · 1 like Authority: if you think a page needs input from someone with specific expertise, suggesting that person helps the maintainer recruit contributors.
Second pass at: A history of disordered eating: proceeding carefully Replied, post #76 · Wellbeing › Mental health · 24 Jun 2025 · 0 likes This follows post #73 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #52 · Clinical › Comorbidities · 15 Jun 2025 · 0 likes Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside the studied populations in most trials. Extrapolating to that…
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #14 · Compounds › Semaglutide · 14 Jun 2025 · 9 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
Coming back to: When "no data" is the complete and final answer Replied, post #12 · Compounds › Other compounds · 12 Jun 2025 · 2 likes Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that regulates appetite. The documented adverse profile includes blood pressure elevation…
Checking someone else's arithmetic: a worked example thread Replied, post #53 · Practice › Reconstitution · 2 Jun 2025 · 0 likes Picking up post #50: that is the part I would want checked first. Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and…
Pregnancy as an absolute contraindication Replied, post #27 · Safety › Contraindications · 17 May 2025 · 3 likes Severe hepatic impairment: less is known than for kidney disease. Extreme caution or contraindication depending on the specific degree of impairment.
Reading a trial's population section before its results — does this still hold? Replied, post #111 · Evidence › Trials · 16 May 2025 · 26 likes I read post #109 twice before replying, because I had assumed the opposite. Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether…
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #65 · Compounds › Secretagogues & GH axis · 8 May 2025 · 16 likes Coming back to post #63, because the follow-up matters more than the original answer. Evidence quality in the secretagogue literature is honestly weaker than in the…
Coverage for the indication versus for the drug Replied, post #49 · Access › Insurance & coverage · 1 May 2025 · 3 likes On post #45 — agreed on the reasoning, with one qualification. Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific…
Shakes versus food: a pragmatic assessment — the long version Replied, post #10 · Nutrition & Training › Protein & intake · 27 Apr 2025 · 0 likes I read post #8 twice before replying, because I had assumed the opposite. Protein supplements: whey, casein, and plant-based protein powders can help hit targets when…
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #84 · Compounds › Semaglutide · 20 Apr 2025 · 5 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Residual solvents and scavengers: what is looked for Replied, post #11 · Analytics › Impurities & related substances · 9 Apr 2025 · 20 likes Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in…
Why plausible mechanism is not evidence of effect Replied, post #3 · marked as the solution · Compounds › Repair & healing peptides · 29 Mar 2025 · 7 likes post #2 answers the question as asked. The question underneath it is different. Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #137 · Sourcing › Vendor reports · 19 Mar 2025 · 29 likes Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a different lot is not evidence about your vial.
Pharmaceutical compounding rules, summarised from primary sources Replied, post #76 · Sourcing › Regulatory · 3 Mar 2025 · 0 likes Off-label use and medical practice: clinicians can prescribe approved medications off-label under some circumstances. That is different from research-use-only…
Protein density versus volume when you cannot eat much Replied, post #84 · Nutrition & Training › Protein & intake · 7 Feb 2025 · 25 likes Timing of protein: spreading protein intake across the day, with some at each meal, is more practical than trying to hit the whole target at one sitting on suppressed…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #113 · Evidence › Journal club · 2 Feb 2025 · 7 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
What we do not know about retatrutide, listed explicitly Replied, post #56 · Compounds › Retatrutide · 15 Jan 2025 · 0 likes The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted attention. It also reported dose-dependent heart-rate increases. The…
[2026 update] New subcategory: rationale and scope Replied, post #114 · Meta › Announcements · 2 Jan 2025 · 12 likes When announcements are made: major policy changes, technical changes affecting site function, planned downtime, and changes to guidelines all get announced here.
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #104 · Analytics › Method validation · 27 Dec 2024 · 28 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #88 · Analytics › Method validation · 5 Dec 2024 · 0 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
Injection-site reactions: describing them precisely enough to be useful Replied, post #15 · Practice › Side effects · 20 Nov 2024 · 14 likes post #14 answers the question as asked. The question underneath it is different. Timeline matters: onset, duration, pattern over days or weeks, relationship to…
Blind submission and why it changes minds Replied, post #87 · Sourcing › Independent verification · 14 Oct 2024 · 25 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
Requesting a page: what makes a good request — what changed since Replied, post #101 · Documentation › Wiki requests · 12 Oct 2024 · 0 likes Scope creep: if you think a page is attempting too much and should be split into multiple pages, that is a reasonable suggestion.
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #89 · Sourcing › Independent verification · 27 Sep 2024 · 2 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
Why a preprint's supplementary material is often the best part Replied, post #17 · Evidence › Preprints · 9 Sep 2024 · 18 likes This follows post #14 rather than contradicting it. Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints…
Tracking a preprint to publication: a worked example — the long version Replied, post #23 · Evidence › Preprints · 5 Aug 2024 · 2 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
Where the four-week escalation interval comes from, and what it is not Replied, post #51 · Practice › Dosing & titration · 17 Jul 2024 · 8 likes Worth separating two things that post #47 runs together. When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea,…
Tracking a preprint to publication: a worked example — the long version Replied, post #6 · Evidence › Preprints · 8 Jun 2024 · 1 like How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.